Methoxychalcone inhibitors of androgen receptor translocation and function
- 1 March 2012
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 22 (5), 2105-2109
- https://doi.org/10.1016/j.bmcl.2011.12.141
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2011
- Developments in Nonsteroidal Antiandrogens Targeting the Androgen ReceptorChemMedChem, 2010
- Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancerTrends in Endocrinology & Metabolism, 2010
- Innovations in the systemic therapy of prostate cancerNature Reviews Clinical Oncology, 2009
- Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established targetThe Lancet Oncology, 2009
- Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate CancerClinical Cancer Research, 2009
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate CancerScience, 2009
- Targeting the androgen receptor pathway in prostate cancerCurrent Opinion in Pharmacology, 2008
- Mechanisms of Disease: the role of heat-shock protein 90 in genitourinary malignancyNature Reviews Endocrinology, 2006
- Chemistry and Structural Biology of Androgen ReceptorChemical Reviews, 2005